Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation

Haematologica

Volumn 93, Issue 9, 2008, Pages 1364-1371

  Zinzani, Pier Luigi ^a   Martelli, Maurizio ^b   Poletti, Venerino ^c   Vitolo, Umberto ^d   Gobbi, Paolo G ^e   Chisesi, Tommaso ^f   Barosi, Giovanni ^e   Ferreri, Andrés J M ^g   Marchetti, Monia ^e   Pimpinelli, Nicola ^h   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chemotherapy; Clinical practice guidelines; Non Hodgkin's lymphoma; Systematic review

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; HUMAN; LUNG CANCER; LYMPHOMA; MEDIASTINUM TUMOR; MEDICAL SOCIETY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRACTICE GUIDELINE; RADIATION DOSE; REVIEW;

ADULT; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; HEMATOLOGY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; ITALY; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; SOCIETIES, MEDICAL;

EID: 50849124773     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12742     Document Type: Review

References (70)

1. Barosi G, Carella A, Lazzarino M, Marchetti M, Martelli M, Rambaldi A, et al. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Haematologica 2005;90:1236-57.
2. Williams PL, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs 1994;19:180-6.
3. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. Br Med J 2001;323:334-6.
4. Delbecq AL, van de Ven AH, Gustafson DH. Group Techniques for Program Planning: A guide to nominal group and Delphi processes. Scott, Foresman and Co, Glenview, IL, USA. 1975
5. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003;139:493-8.
6. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630-6.
7. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. The International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579-86.
8. Chilosi M, Poletti V, Zinzani PL. Lymphoproliferative lung disorders. Semin Respir Crit Care Med 2005;26:490-501.
9. Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Invest 2006;116:22-6.
10. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360-73.
11. Nicholson AG, Wotherspoon AC, Diss TC, Singh N, Butcher DN, Pan LX, et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein Barr virus associated B cell lymphoma. Histopathology 1996;29:317-24.
12. Lee BH, Kim SY, Hwang YJ, Hwang YJ, Han YH, Seo JW, et al. CT of nasal type T/NK cell lymphoma in the lung. J Thorac Imaging 2006;21:37-9.
13. Troch M, Streubel B, Petkov V, Turetschek K, Chott A, Rader M. Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res 2007;27:3633-7.
14. Koss M, Hochholzer L, Nichols PW, Wehunt WD, Lazarus AA. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol 1983;14:1024-38.
15. Kennedy JL, Natwani BM, Burke JS, Hill LR, Rappaport H. Pulmonary lymphomas and other pulmonary lymphoid lesions. A clinicopathologic and immunologic study of 64 patients. Cancer 1985;56:539-52.
16. Li G, Hansmann ML, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990;16:519-31.
17. Cordier JF, Chailleux E, Lauque D, Reynaud-Gaubert M, Dietemann-Molard A, Dalphin JC, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993;103:201-8.
18. Fiche M, Caprons F, Berger F, Galateau F, Cordier JF, Loire R, et al. Primary pulmonary non-Hodgkin's lymphomas. Histopathology 1995;26:529-37.
19. Wislez M, Cadranel J, Antoine M, Milleron B, Bazot M, Mayaud C, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999;14:423-9.
20. Ferraro P, Trastek VF, Adlakha H, Deschamps C, Allen MS, Pairolero PC. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 2000;69:993-7.
21. Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001;25:997-1008.
22. Zinzani PL, Tani M, Gabriele A, Poletti V, Stefoni V, Alinari L, et al. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single experience with 12 patients. Leuk Lymphoma 2003;44:821-4.
23. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. International Extranodal Lymphoma Study Group. Blood 2003;101:2489-95.
24. Ahmed S, Kussick SJ, Siddiqui AK, Bhuiya TA, Khan A, Sarewitz S, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004;40:1320-9.
25. Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg 2005;80:1248-53.
26. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003;21:4157-64.
27. Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004;100:2190-4.
28. Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002; 20:3872-7.
29. Jäger G, Neumeister P, Ouehenberger F, Wohrer S, Linkesch W, Raderer M. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial. Ann Oncol 2006;11:1722-3.
30. Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, et al. Phase II study of Oxaliplatinum for treatment of patients with mucosa associated lymphoid tissue lymphoma. J Clin Oncol 2005;23:8442-6.
31. Conconi A, Martinelli G, Thiéblemont C, Ferreri AJ, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-5.
32. Raderer M, Jäger G, Brugger S, Püspök A, Fiebiger W, Drach J, et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003;65:306-10.
33. Chong EA, Svoboda J, Cherian S, Andreadis C, Downs LH, Zhuang H, et al. Regression of pulmonary MALT lymphoma after treatment with rituximab. Leuk Lymphoma 2005;46:1383-6.
34. Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 1996;20:877-88.
35. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003;198:851-62.
36. Palanisamy N, Abou-Elella AA, Chaganti SR, Houldsworth J, Offit K, Louie DC, et al. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer 2002;33:114-22.
37. Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 2004;11:227-38.
38. Wessendorf S, Barth TF, Viardot A, Mueller A, Kestler HA, Kohlhammer H, et al. Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Leukemia 2007;21:2463-9.
39. Levitt LJ, Aisenberg AC, Harris NL, Linggood RM, Poppema S. Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 1982;50:2486-92.
40. Lazzarino M, Orlandi E, Paulli M, Sträter J, Klersy C, Gianelli U, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol 1997;15:1646-53.
41. Zinzani PL, Bendandi M, Frezza G, Gherlinzoni F, Merla E, Salvucci M, et al. Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 1996;21:311-6.
42. Abrahamsen AF, Lien HH, Aas M, Winderen M, Hager B, Kvaløy S, et al. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study. Ann Oncol 1994;5:433-6.
43. Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67) gallium scan in 50 patients. Blood 1999;94:3289-93.
44. Jacobson JO, Aisenberg AC, Lamarre L, Willett CG, Linggood RM, Miketic LM, et al. Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988;62:1893-8.
45. Haioun C, Gaulard P, Roudot-Thoraval F, Divine M, Jouault H, Lebourgeois JP, et al. Mediastinal diffuse large B-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol 1989;12:425-9.
46. Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic and pathologic features in 57 patients. J Clin Oncol 1993;11:1336-43.
47. Aisenberg AC. Primary large-cell lymphoma of the mediastinum. J Clin Oncol 1993;11:2291-8.
48. Rodriguez J, Pugh WC, Romaguera JE, Cabanillas F. Primary mediastinal large cell lymphoma. Haematol Oncol 1994;12:175-84.
49. Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol 1999;17:784-90.
50. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Clin Pathol 1986;10:176-91.
51. al-Sharabati M, Chittal S, Duga-Neulat I, Laurent G, Mazerolles C, al-Saati T, et al. Primary anterior mediastinal B-cell lymphoma: a clinicopathological and immunohistochemical study of 16 cases. Cancer 1991;67:2579-83.
52. Bieri S, Roggero E, Zucca E, Bertoni F, Pianca S, Sanna P, et al. Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials. Leuk Lymphoma 1999;35:139-46.
53. Nguyen LN, Ha CS, Hess M, Romaguera JE, Manning JT, Cabanillas F, et al. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum. Int Radiat Oncol Biol Physicians 2000;47:1281-5.
54. Falini B, Venturi S, Martelli M, Santucci A, Pileri S, Pescarmona E, et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 1995;89:780-9.
55. Lazzarino M, Orlandi E, Paulli M, Boveri E, Morra E, Brusamolino E, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathological features. J Clin Oncol 1993;11:2306-13.
56. Bertini M, Orsucci L, Vitolo U, Levis A, Todeschini G, Meneghini V, et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 1991;2:733-7.
57. Todeschini G, Ambrosetti A, Meneghini V, Pizzolo G, Menestrina F, Chilosi M, et al. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990;8:804-8.
58. Martelli MP, Martelli M, Pescarmona E, De Sanctis V, Donato V, Palombi F, et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 1998;9:1027-9.
59. Zinzani PL, Martelli M, De Renzo A, De Renzo A, Zaccaria A, Pavone E, et al. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 2001;86:187-91.
60. Hamlin PA, Portlock CS, Straus DJ, Noy A, Singer A, Horwitz SM, et al. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol 2005;130:691-9.
61. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;329:1002-6.
62. Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002;87:1258-64.
63. Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, et al. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 2004;90:372-6.
64. Nademanee A, Molina A, O'Donnell M, Dagis A, Snyder DS, Parker P, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate and high-grade lymphoma: international index high and high-intermediate risk group. Blood 1997;90:3844-52.
65. Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998;16:63-9.
66. Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, et al. Primary diffuse large B-cell lymphoma of the mediastinum. Outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 1998;91:717-23.
67. Dunleavy K, Pittaluga S, Janik J. Primary mediastinal large B-cell lymphoma (PMBL) outcome is significantly improved by the addition of rituximab to dose-adjusted (DA)-EPOCH and overcomes the need for radiation. Blood 2005;106:273a [abstract].
68. Vassilakopoulos TP, Angelopoulou MK, Galani Z. Rituximab-CHOP and radiotherapy mediastinal large B-cell lymphoma: an update. Haematologica 2006;91:704.
69. Martelli M, Stefoni V, Cabras P. Rituximab-M/VACOP-B combined with radiotherapy in primary mediastinal large B cell lymphoma: a prospective Italian intergroup phase II study. Haematologica 2006;91:184[Abstract].
70. Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, et al. Favourable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006;17:123-30.